Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 03, 2015
Catalent has announced that Dr. Donald E. Morel will be added to its Board of Directors, effective the next time the Board convenes, increasing the size of the Board to ten members.
read more
Wednesday, November 04, 2015
Bristol-Myers Squibb has entered into a collaboration agreement with The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as part of Bristol-Myers Squibb’s Immuno-Oncology Rare Population Malignancy (I-O RPM) program in the U.S.
read more
Thursday, November 05, 2015
Precision for Value has acquired Redwood Outcomes, an international health economics and outcomes research (HEOR) company.
read more
Thursday, November 05, 2015
The U.S. health care system saved a record $254 billion in 2014 from generic drugs, which amounts to $1.68 trillion over the most recent decade (2005-2014), according to the seventh annual Generic Drug Savings in the United States report compiled by ...
read more
Thursday, November 05, 2015
Unilife Corporation a U.S. based designer, developer and supplier of injectable drug delivery systems, has announced the signing of the first supply agreement under its November 2013 Master Development and Supply Agreement ("MDSA") with MedImmune, ...
read more
Thursday, November 05, 2015
Medivo, Inc., a lab data analytics company, announced that it has formed a nonexclusive laboratory data licensing agreement with Quest Diagnostics, a provider of diagnostic information services.
read more
Thursday, November 05, 2015
Mylan has announced that the U.S. Federal Trade Commission has cleared the company's proposed transaction to acquire Perrigo Company subject to Mylan's divestiture of certain products following the consummation of the offer.
read more
Thursday, November 05, 2015
MabVax Therapeutics Holdings, a clinical-stage oncology drug development company, has completed manufacturing of the bulk clinical-quality drug substance of HuMab 5B1 in preparation for the planned initiation of two Phase I clinical trials with this ...
read more
Friday, November 06, 2015
Exostar, a provider of secure cloud-based solutions that improve identity access management, is now certified by SAFE-BioPharma Association to issue SHA-2 compliant public key infrastructure (PKI) digital certificates for use in the life sciences and...
read more
Friday, November 06, 2015
The U.S. Food and Drug Administration has approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older.
read more
Friday, November 06, 2015
TapImmune, a clinical-stage immune-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, announced today that it has relocated its ...
read more
Friday, November 06, 2015
The Pulmonary Fibrosis Foundation (PFF), the leading pulmonary fibrosis resource, has announced that Genentech, a leading biotechnology company and a member of the Roche Group, will be the Founding Partner for the PFF Patient Registry program ...
read more
Friday, November 06, 2015
AstraZeneca has entered into a definitive agreement to acquire ZS Pharma, a biopharmaceutical company based in San Mateo, California.
read more
Friday, November 06, 2015
Sanofi and Hanmi Pharmaceutical Co., Ltd. have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments
read more
Tuesday, November 10, 2015
PAREXEL International Corporation, a global biopharmaceutical services provider, has announced expanded evidence-based services for biopharmaceutical products.
read more